37
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Secukinumab for Severe Hidradenitis Suppurativa in a Patient on Haemodialysis: Efficacy and Safety on 300 mg Every 2 Weeks Administration – A Case Report

ORCID Icon, , ORCID Icon, , ORCID Icon &
Pages 1275-1279 | Received 05 Apr 2024, Accepted 26 May 2024, Published online: 30 May 2024